About
Restore Medical is an Israeli clinical-stage MedTech company founded in 2019, focused on innovative treatments for congestive heart failure (CHF), particularly heart failure with reduced ejection fraction (HFrEF). The company is led by CEO Gilad Marom and co-founders Stephen Bellomo, Dr. Elchanan Bruckheimer, and Aaron Feldman. It is supported by notable investors, including Pitango HealthTech and the European Innovation Council (EIC) Fund. The company's flagship product, ContraBand™, is the first transcatheter Pulmonary Artery Banding (PAB) system designed to treat left ventricular failure in heart failure patients. This catheter-delivered, reversible implant aims to improve left ventricular ejection fraction and restore optimal ventricular geometry. ContraBand™ is currently undergoing clinical trials, including a European feasibility study and a U.S.-based study, and has received FDA Breakthrough Device designation. Restore Medical targets healthcare providers and institutions that treat CHF patients, offering a minimally invasive solution to enhance patient outcomes.
Technologies
Keywords
Company Information
- Employees14
- Founded2019
- Total Funding$25643975
Location
5 יהונתן נתניהו, Or Yehuda, Tel Aviv District, Israel, 6037603
